Chronic hepatitis B virus infection is closely associated with the dev
elopment of hepatocellular carcinoma, which is a major cause of cancer
death worldwide. Recent studies have implicated hepatitis C virus inf
ection as a major pathogenic agent of HBsAg-negative hepatocellular ca
rcinoma. The significance of hepatitis C virus and hepatitis B virus i
nfections in the occurrence of HBsAg-negative hepatocellular carcinoma
has not been well established in the United States. We studied 91 HBs
Ag-negative American patients with hepatocellular carcinoma for eviden
ce of hepatitis C virus or hepatitis B virus infection. These patients
had no other predisposing factors to hepatocellular carcinoma. A sens
itive polymerase chain reaction was employed to detect hepatitis C vir
us RNA and hepatitis B virus DNA in serum and liver. Three sets of hep
atitis C virus and hepatitis B virus primers were used to optimize the
detection of viral genomes. Hepatitis C virus antibodies were measure
d with second-generation immunoassays. Twenty-six (29%) of these patie
nts carried low levels of hepatitis B virus DNA in either serum, liver
/tumor tissue or both. On the basis of the results from serological an
d polymerase chain reaction analyses of serum and liver, we found that
53 of 91 patients (58%) exhibited evidence of hepatitis C virus infec
tion. When data were combined, 14 patients (15%) had evidence of hepat
itis B virus/hepatitis C virus coinfection, whereas 12 (13%) were infe
cted with hepatitis B virus alone and 39 (43%) had hepatitis C virus o
nly. Twenty-six (29%) had no markers of hepatitis B virus or hepatitis
C virus infection. All patients with identifiable viral markers had c
oexisting chronic liver disease. Our study suggests that hepatitis C v
irus and occult hepatitis B virus infections account for most (71%) he
patocellular carcinoma cases of unknown pathogenesis in the United Sta
tes. However, in some patients with hepatocellular carcinoma no define
d pathogenesis is associated with development of disease.